Back to News
Market Impact: 0.45
United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
Source: 247wallst.com
Legal & LitigationPatents & Intellectual PropertyCompany Fundamentals
A patent court ruling erased nearly half of Liquidia’s stock value in one day. The subsequent settlement cost the company almost every dollar it had in the bank.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.75
Ticker Sentiment
LQDA-0.90
More News
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation
- Anthropic's third-quarter revenue is said to hit $16.8 billion ahead of IPO
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- US Stocks Tumble as Chip Rout Deepens
- Bank of America Has 'Accountability' in Face of Fines, Says Moynihan